These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 8801102)

  • 21. Accuracy of final height prediction and effect of growth-reductive therapy in 362 constitutionally tall children.
    de Waal WJ; Greyn-Fokker MH; Stijnen T; van Gurp EA; Toolens AM; de Munick Keizer-Schrama SM; Aarsen RS; Drop SL
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1206-16. PubMed ID: 8772601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Final height outcome in girls with Turner syndrome treated with a combination of low dose oestrogen and oxandrolone.
    Bareille P; Massarano AA; Stanhope R
    Eur J Pediatr; 1997 May; 156(5):358-62. PubMed ID: 9177976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxandrolone induces a sustained rise in physiological growth hormone secretion in boys with constitutional delay of growth and puberty.
    Stanhope R; Hindmarsh P; Pringle PJ; Holownia P; Honour J; Brook CG
    Pediatrician; 1987; 14(3):183-8. PubMed ID: 3453497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal monitoring of bone accretion measured by quantitative multi-site ultrasound (QUS) of bones in patients with delayed puberty (a pilot study).
    Zadik Z; Sinai T; Borondukov E; Zung A; Yaniv I; Reifen R
    Osteoporos Int; 2005 Sep; 16(9):1036-41. PubMed ID: 15616757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxandrolone for delayed puberty in boys taking long-term steroid therapy for renal disease.
    Rees L; Greene SA; Rigden SP; Haycock GB; Chantler C; Preece MA
    Pediatr Nephrol; 1990 Mar; 4(2):160-2. PubMed ID: 2397183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Favorable final height outcome in girls with Ullrich-Turner syndrome treated with low-dose growth hormone together with oxandrolone despite starting treatment after 10 years of age.
    Stahnke N; Keller E; Landy H;
    J Pediatr Endocrinol Metab; 2002 Feb; 15(2):129-38. PubMed ID: 11874177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Final height in a patient with Laron syndrome after long-term therapy with rhlGF-I and short-term therapy with LHRH-analogue and oxandrolone during puberty.
    Zucchini S; Scarano E; Baldazzi L; Mazzanti L; Pirazzoli P; Cacciari E
    J Endocrinol Invest; 2005 Mar; 28(3):274-9. PubMed ID: 15952414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are short boys with constitutional delay of growth and puberty candidates for rGH therapy according to FDA recommendations?
    Krajewska-Siuda E; Malecka-Tendera E; Krajewski-Siuda K
    Horm Res; 2006; 65(4):192-6. PubMed ID: 16549932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty.
    Lanes R; Gunczler P
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):197-202. PubMed ID: 9828907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of growth delay in boys with isolated growth hormone deficiency.
    Albanese A; Stanhope R
    Eur J Endocrinol; 1994 Jan; 130(1):65-9. PubMed ID: 8124480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long term treatment with low dose testosterone in constitutional delay of growth and puberty: effect on bone age maturation and pubertal progression.
    Bergadá I; Bergadá C
    J Pediatr Endocrinol Metab; 1995; 8(2):117-22. PubMed ID: 7584705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of short-term growth hormone or low-dose oxandrolone treatment in boys with constitutional growth delay.
    Loche S; Pintor C; Cambiaso P; Lampis A; Carta D; Corda R; Cappa M
    J Endocrinol Invest; 1991 Oct; 14(9):747-50. PubMed ID: 1761810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of constitutional delay of growth and puberty with oxandrolone compared with growth hormone.
    Buyukgebiz A; Hindmarsh PC; Brook CG
    Arch Dis Child; 1990 Apr; 65(4):448-9. PubMed ID: 2346341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of early puberty in a boy after treatment with oxandrolone?
    Doeker B; Müller-Michaels J; Andler W
    Horm Res; 1998; 50(1):46-8. PubMed ID: 9691214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term results of treatment with low-dose fluoxymesterone in constitutional delay of growth and puberty and in genetic short stature.
    Strickland AL
    Pediatrics; 1993 Apr; 91(4):716-20. PubMed ID: 8464656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Final height and body disproportion in thalassaemic boys and girls with spontaneous or induced puberty.
    Filosa A; Di Maio S; Baron I; Esposito G; Galati MG
    Acta Paediatr; 2000 Nov; 89(11):1295-301. PubMed ID: 11106039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
    Pasquino AM; Pucarelli I; Roggini M; Segni M
    J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth promotion by oxandrolone in a girl with short stature and early pubertal development treated with growth hormone and gonadotropin-releasing hormone-analogue. A case study.
    Hermanussen M
    Acta Paediatr; 1995 Oct; 84(10):1207-10. PubMed ID: 8563241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Degree of activation of the pituitary-testicular axis in early pubertal boys with constitutional delay of growth and puberty determines the growth response to treatment with testosterone or oxandrolone.
    Crowne EC; Wallace WH; Moore C; Mitchell R; Robertson WR; Shalet SM
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1869-75. PubMed ID: 7775634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progressive reduction of relative height in childhood predicts adult stature below target height in boys with constitutional delay of growth and puberty.
    Wehkalampi K; Vangonen K; Laine T; Dunkel L
    Horm Res; 2007; 68(2):99-104. PubMed ID: 17377395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.